|
|
||||||||
RAPID COMMUNICATIONS |
a Departments of General Surgery,
b Cardiothoracic Surgery,
c Diagnostic Radiology,
d Hemostaseology and Transfusion Medicine, and
e Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-University of Duesseldorf, Duesseldorf, Germany,
f Institute of Clinical Pharmacology, University of Witten/Herdecke, Witten, Germany
Key Words. Adult bone marrow stem cells • Liver regeneration • AC133 antigen • Somatic cell therapy • Clinical trials • Clinical stem cell transplantation
Correspondence: Wolfram Trudo Knoefel, M.D., F.A.C.S., Department of General Surgery, Heinrich-Heine-University of Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany. Telephone: 49-211-8117350/51; Fax: 49-211-8117359; e-mail: knoefel{at}uni-duesseldorf.de
The liver has a large capacity for regeneration after resection. However, below a critical level of future liver remnant volume (FLRV), partial hepatectomy is accompanied by a significant increase of postoperative liver failure. There is accumulating evidence for the contribution of bone marrow stem cells (BMSCs) to participate in liver regeneration. Here we report on three patients subjected to intraportal administration of autologous CD133+ BMSCs subsequent to portal venous embolization of right liver segments, used to expand left lateral hepatic segments as FLRV. Computerized tomography scan volumetry revealed 2.5-fold increased mean proliferation rates of left lateral segments compared with a group of three consecutive patients treated without application of BMSCs. This early experience with portovenous application of CD133+ BMSCs could suggest that this novel therapeutic approach bears the potential of enhancing and accelerating hepatic regeneration in a clinical setting.
This article has been cited by other articles:
![]() |
R. K. Burt, Y. Loh, W. Pearce, N. Beohar, W. G. Barr, R. Craig, Y. Wen, J. A. Rapp, and J. Kessler Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases JAMA, February 27, 2008; 299(8): 925 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Forbes Stem cell therapy for chronic liver disease choosing the right tools for the job Gut, February 1, 2008; 57(2): 153 - 155. [Full Text] [PDF] |
||||
![]() |
F. Ozkan, B. Peynircioglu, B. E. Cil, G. Furst, J. S. a. Esch, L. B. Fritz, E. Godehardt, U. Modder, and W. T. Knoefel Portal Vein Embolization and Stem Cell Administration Radiology, February 1, 2008; 246(2): 646 - 647. [Full Text] [PDF] |
||||
![]() |
Y N Kallis, M R Alison, and S J Forbes Bone marrow stem cells and liver disease Gut, May 1, 2007; 56(5): 716 - 724. [Full Text] [PDF] |
||||
![]() |
G. Furst, J. Schulte am Esch, L. W. Poll, S. B. Hosch, L. B. Fritz, M. Klein, E. Godehardt, A. Krieg, B. Wecker, V. Stoldt, et al. Portal Vein Embolization and Autologous CD133+ Bone Marrow Stem Cells for Liver Regeneration: Initial Experience Radiology, April 1, 2007; 243(1): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Popp, P. Slowik, E. Eggenhofer, P. Renner, S. A. Lang, O. Stoeltzing, E. K. Geissler, P. Piso, H. J. Schlitt, and M. H. Dahlke No Contribution of Multipotent Mesenchymal Stromal Cells to Liver Regeneration in a Rat Model of Prolonged Hepatic Injury Stem Cells, March 1, 2007; 25(3): 639 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lemoli, L. Catani, S. Talarico, E. Loggi, A. Gramenzi, U. Baccarani, M. Fogli, G. L. Grazi, M. Aluigi, G. Marzocchi, et al. Mobilization of Bone Marrow-Derived Hematopoietic and Endothelial Stem Cells After Orthotopic Liver Transplantation and Liver Resection Stem Cells, December 1, 2006; 24(12): 2817 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terai, T. Ishikawa, K. Omori, K. Aoyama, Y. Marumoto, Y. Urata, Y. Yokoyama, K. Uchida, T. Yamasaki, Y. Fujii, et al. Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy Stem Cells, October 1, 2006; 24(10): 2292 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Gordon, N. Levicar, M. Pai, P. Bachellier, I. Dimarakis, F. Al-Allaf, H. M'Hamdi, T. Thalji, J. P. Welsh, S. B. Marley, et al. Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor Stem Cells, July 1, 2006; 24(7): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
